Washington, Oct 2 (ANI): A new study on rats suggests that a combined treatment with rapamycin and Gleevec might reverse the effects of portal hypertension in patients with chronic liver disease. Previous studies have suggested that anti-angiogenic treatment might help prevent the progression of the portal hypertension syndrome. Vascular endothelial growth factor (VEGF) and platelet-derived ...
Read More...
[Source: Yahoo! News Search Results for liver disease help]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment